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24S Abstracts May Supplement 2013estimates of survival at 1, 3 and 5-years were 85.8%, 81.4%
and 69.7%. Two reinterventions for endoleak were required
and no migration or late aneurysm related mortality was
recorded.
Conclusions: The incidence of stroke is acceptable
after both total and partial arch debranching. Total
debranching is an important predictor for mortality. Retro-
grade dissection may be infrequent complication with care-
ful arch approach. After the perioperative interval,
debranching is a safe and durable procedure up to 5 years.
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Objectives: Using the CHAP database of nearly
10,000 patients nationwide, we examined eligibility for
EVAR in patients with a short neck AAA (snAAA), where
the neck length < 10 mm, and identiﬁed the anatomic
parameters driving endograft (EVG) ineligibility.
Methods: Preoperative CT scans from eleven US clin-
ical sites were prospectively entered into a database from
7/96 to 11/12. A blinded third-party, M2S, recorded
standardized measurements from the 3D reconstructions.
Two currently marketed EVG in the US are labeled to treat
snAAA, with neck angulation #45 deg and neck lengthsTable. Eligibility for two marketed EVGs excluding iliac and
anatomic parameters
snAAA < 5 cm snAAA $ 5 c
M (512) W (324) M (1733) W
Cook fenestrated, % 44 44 42
Trivascular ovation, % 24 10 16
Neck length, mm 6 (3-9) 5 (2-9) 6 (2-9) 5
Neck angulation, deg 31 (16-55) 38 (18-63) 37 (18-61) 48
Neck diameter, mm 24 (26-35) 23 (18-34) 25 (20-97) 24$4 mm (Cook Fenestrated) and >7 mm (Trivascular
Ovation). The EVAR criteria were analyzed in 2245 men
(M) and 1079 women (W) with snAAA.
Results: Of the 9848 AAAs, 3324 have snAAA (34%).
Even if iliac and access criteria are excluded, EVAR eligi-
bility for snAAA is at most 45%. In snAAA >5 cm diam-
eter, neck angulation is 48 deg for women and 37 deg
for men (P < .01). Women are more likely to have neck
length < 4 mm and neck angulation > 45 deg (risk ratio
is 90). Only 6% of patients are eligible for both EVG.
Larger AAAs are not less likely to be eligible for fenestrated
EVAR (Table; P ¼ NS).
Conclusions: One-third of AAAs have a short neck,
and less than half of these are eligible for current EVG,
even with a fenestrated option. Neck angulation and length
continue to challenge EVAR eligibility, especially for
women. Eligibility for EVAR does not lessen as aneurysms
enlarge, so there is no indication for early repair.
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Video Presentation
Percutaneous Endovascular Repair of Aortoiliac
Aneurysm Using Iliac Branch Device
Mateus P. Correa, Gustavo S. Oderich. Division of Vascular
and Endovascular Surgery, Mayo Clinic, Rochester, Minn
Background: Exclusion of one or both internal iliac
arteries (IIA) during endovascular aortic aneurysm repair
(EVAR) has been associated with a predictable rate of
pelvic ischemic complications. We present the preoperative
planning and technique of implantation of Iliac Branch
Device (IBD, Cook Inc., Brisbane, Australia) in a patient
with bilateral common iliac artery (CIA) aneurysms using
total percutaneous approach.
Technical Description: Computed tomography angi-
ography (CTA) was used to determine measurementsaccess criteria; median (10th-90th percentile) values of
m snAAA > 5.5 cm snAAA > 6.5 cm
(755) M (1152) W (437) M (465) W (154)
45 45 45 45 43
7 14 6 18 3
(2-9) 6 (2 9) 5 (2-9) 5 (2 9) 4 (1-8)
(25-74) 39 (19 64) 51 (28-77) 43 (20 67) 57 (32-81)
(19-37) 25 (21 38) 24 (19-39) 26 (21 41) 24 (19-42)
